The history of Leica Biosystems is a history of science and technology innovation. 150+ years we’ve tackled pathology challenges head on, from better slide production to world‑leading Digital Pathology empowering AI development. Our passionate experts drive our mission of Advancing Cancer Diagnostics, Improving Lives.
The BOND-III stainer provides you with all of the pieces to solve the diagnostic puzzle quickly and consistently. Maximize your lab space with this compact solution that combines efficiency and organization, allowing you to achieve up to 60% more slide throughput per m2* compared to other leading instruments on the market.*
The Aperio GT 450 enables histotechnicians to complete scanning tasks quickly and with confidence leveraging a 32-second scan speed*. Output 81 slides/hr at 40x* delivering high quality images with Leica optics and with an IT architecture that is secure and scalable. From the pathology lab to the IT room, the Aperio GT 450 is designed to scale up digital pathology operations. **
LEARN MORE
Give every tissue type and size the treatment it deserves. Establish a workflow that meets the demands of your laboratory without compromises on tissue quality. The HistoCore PEGASUS tissue processor enables you to run multiple protocols in parallel on a single instrument, ensuring optimal conditions for all tissue types without slowing down your laboratory.***
Your time matters. Speed up slide processing while maintaining quality and consistency with the HistoCore SPECTRA Workstation, the only workstation that provides consistent staining from slides 1 to 1,600. It also offers the fastest glass coverslipping drying time on the market at only 5 minutes, processing slides that are instantly dry to the touch.****
Fewer resources, more to do, and less time to get work done. While we can’t eliminate these pressures, we can help you make the most of each minute, meet your metrics, and consistently deliver slides on-time.
Whether delivering clinical diagnostics or the next research breakthrough, every moment matters. There is constant pressure to quickly produce reliable results. Meet the challenge with solutions engineered to address today’s needs and tomorrow’s opportunities.
Adopting digital pathology is complex, but it doesn’t have to be complicated. Leica Biosystems can clarify your organization’s path to digitally driven discoveries or diagnostics. Our world-leading, modular technology is supported by experience with thousands of Aperio Digital Pathology implementations worldwide.
Leica Biosystems is a global leader in workflow solutions and automation, integrating each step in the process. As the only company to own the workflow from biopsy to diagnosis, we are uniquely positioned to break down the barriers between each of these steps. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
If you have an idea, product or technology that you believe could make a step forward in advancing cancer diagnostics, please do not hesitate to reach out.
* For in vitro diagnostic use
** For In Vitro Diagnostic Use.
The clinical use claims described for the products in the information supplied have not been cleared or approved by the U.S. FDA or are not available in the United States.
*** For In-Vitro Diagnostic Use
**** Histocore SPECTRA is a trademark of the Leica Biosystems group of companies in the USA and optionally in other countries. Other logos, product and/or company names might be trademarks of their respective owners.
